X-group (possible homology)

227 DNA clamp

Ligands and drugs

3,396
Member domains
596
with ligand contacts (≤ 4 Å)
17.6% of members
549
with DrugDomain annotations
16.2% of members
257
with a DrugBank compound
7.6% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

29
Proteins with classified ligands
8
Superclasses bound (of 23)
7.6
Superclasses per 20 proteins
narrower than 51% of the 256 X-groups with enough proteins to compare (median 7.6)

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Homogeneous non-metal compounds156.22.44×q = 7.9e-4
Organic oxygen compounds95.71.58×q = 0.21
Homogeneous metal compounds1414.01.00×q = 1.00
Nucleosides, nucleotides, and analogues07.90q = 5.5e-4
Hydrocarbons10.25.01×not tested
Organosulfur compounds20.63.40×not tested
Benzenoids42.11.91×not tested
Organic acids and derivatives64.41.36×not tested
Organoheterocyclic compounds44.40.91×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00120PHEPhenylalanine4
DB00125ARGArginine4
DB00149LEULeucine4
DB00738PNTPentamidine4
DB008611FLDiflunisal4
DB02967NEQN-Ethylmaleimide4
DB06998322[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid4
DB00142GLUGlutamic acid2
DB00156THRThreonine2
DB00279T3Liothyronine2
DB00945—Acetylsalicylic acid2
DB0096327RBromfenac2
DB02159PGR(R)-Propylene glycol2
DB031006NI6-Nitroindazole2
DB071084FC4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID2
DB02078PG5Triglyme1

Most frequently bound compounds

PDB ligandNameDomains in contact
CAmetalCALCIUM ION105
CLCHLORIDE ION74
NAmetalSODIUM ION36
BRBROMIDE ION18
ZNmetalZINC ION16
ACEACETYL GROUP10
MGmetalMAGNESIUM ION10
IODIODIDE ION6
NEQN-ETHYLMALEIMIDE6
KmetalPOTASSIUM ION5
0LA(2S)-2-(6-chloro-9H-carbazol-2-yl)propanoic acid4
1FL5-(2,4-DIFLUOROPHENYL)-2-HYDROXY-BENZOIC ACID4
2HO3,4-difluorobenzamide4
2HQ5-chloro-1H-indole-2,3-dione4
2VD(2R)-6-bromo-9-(2-{[(1R)-1-carboxy-2-phenylethyl]amino}-2-oxoethyl)-2,3,4,9-tetrahydro-1H-carbazole-2-carboxylic acid4
2VF(2R)-9-(2-amino-2-oxoethyl)-6-chloro-2,3,4,9-tetrahydro-1H-carbazole-2-carboxylic acid4
2VG(2R)-6-chloro-2,3,4,9-tetrahydro-1H-carbazole-2-carboxylic acid4
2VM(2R)-6-bromo-9-(2-{[(1S)-1-carboxy-2-phenylethyl]amino}-2-oxoethyl)-2,3,4,9-tetrahydro-1H-carbazole-2-carboxylic acid4
322[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid4
743(1R,5R)-5-{(1Z)-N-[(4'-fluorobiphenyl-4-yl)methoxy]butanimidoyl}-2,2-dimethyl-4,6-dioxocyclohexanecarbonitrile4